Jeffrey Lieberman: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|American psychiatrist and researcher}} | ||
'''Jeffrey | {{Use mdy dates|date=October 2023}} | ||
== Jeffrey Lieberman == | |||
[[File:Jeffrey_Lieberman.jpg|thumb|right|Jeffrey Lieberman]] | |||
[[ | '''Jeffrey Alan Lieberman''' is an American psychiatrist known for his research in the field of [[schizophrenia]] and [[psychopharmacology]]. He has held prominent positions in academic psychiatry and has contributed significantly to the understanding and treatment of mental disorders. | ||
== Early Life and Education == | |||
Jeffrey Lieberman was born in the United States. He pursued his undergraduate education at [[Miami University]] in [[Oxford, Ohio]], where he developed an interest in the biological basis of behavior. He went on to attend medical school at the [[George Washington University School of Medicine & Health Sciences]], where he earned his [[Doctor of Medicine|M.D.]] degree. | |||
== Career == | |||
Lieberman completed his residency in psychiatry at the [[St. Vincent's Hospital]] in New York City. He furthered his training with a fellowship in psychopharmacology at the [[Albert Einstein College of Medicine]]. | |||
=== Academic Positions === | |||
Lieberman has held several academic positions throughout his career. He served as the Chairman of the Department of Psychiatry at the [[Columbia University College of Physicians and Surgeons]]. He was also the Director of the New York State Psychiatric Institute and the Psychiatrist-in-Chief at the [[NewYork-Presbyterian Hospital]]. | |||
=== Research Contributions === | |||
Lieberman's research has focused on the neurobiology and treatment of schizophrenia. He has been involved in numerous clinical trials and has published extensively on the efficacy and safety of antipsychotic medications. His work has contributed to the development of new treatment strategies for schizophrenia and other severe mental illnesses. | |||
== Professional Leadership == | |||
Lieberman has served as the President of the [[American Psychiatric Association]] (APA), where he advocated for mental health policy reform and the destigmatization of mental illness. During his tenure, he emphasized the importance of integrating mental health care into primary care settings. | |||
== Publications == | |||
Lieberman is the author of several books and numerous scientific articles. His publications have addressed various aspects of psychiatry, including the pathophysiology of mental disorders and the development of novel therapeutic approaches. | |||
== Related Pages == | |||
* [[Schizophrenia]] | |||
* [[Psychopharmacology]] | |||
* [[American Psychiatric Association]] | |||
* [[Columbia University College of Physicians and Surgeons]] | |||
[[Category:American psychiatrists]] | [[Category:American psychiatrists]] | ||
[[Category:Schizophrenia researchers]] | |||
[[Category:Columbia University faculty]] | |||
[[Category:Living people]] | |||
Latest revision as of 11:27, 15 February 2025
American psychiatrist and researcher
Jeffrey Lieberman[edit]
Jeffrey Alan Lieberman is an American psychiatrist known for his research in the field of schizophrenia and psychopharmacology. He has held prominent positions in academic psychiatry and has contributed significantly to the understanding and treatment of mental disorders.
Early Life and Education[edit]
Jeffrey Lieberman was born in the United States. He pursued his undergraduate education at Miami University in Oxford, Ohio, where he developed an interest in the biological basis of behavior. He went on to attend medical school at the George Washington University School of Medicine & Health Sciences, where he earned his M.D. degree.
Career[edit]
Lieberman completed his residency in psychiatry at the St. Vincent's Hospital in New York City. He furthered his training with a fellowship in psychopharmacology at the Albert Einstein College of Medicine.
Academic Positions[edit]
Lieberman has held several academic positions throughout his career. He served as the Chairman of the Department of Psychiatry at the Columbia University College of Physicians and Surgeons. He was also the Director of the New York State Psychiatric Institute and the Psychiatrist-in-Chief at the NewYork-Presbyterian Hospital.
Research Contributions[edit]
Lieberman's research has focused on the neurobiology and treatment of schizophrenia. He has been involved in numerous clinical trials and has published extensively on the efficacy and safety of antipsychotic medications. His work has contributed to the development of new treatment strategies for schizophrenia and other severe mental illnesses.
Professional Leadership[edit]
Lieberman has served as the President of the American Psychiatric Association (APA), where he advocated for mental health policy reform and the destigmatization of mental illness. During his tenure, he emphasized the importance of integrating mental health care into primary care settings.
Publications[edit]
Lieberman is the author of several books and numerous scientific articles. His publications have addressed various aspects of psychiatry, including the pathophysiology of mental disorders and the development of novel therapeutic approaches.
